Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability. HIF-1 alpha is the oxygen-regulated subunit of HIF-1, an alpha beta heterodimeric complex. HIF-1 alpha is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degradation by the ubiquitination complex pVHL, the protein of the von Hippel Lindau (VHL) tumour suppressor gene and a component of an E3 ubiquitin ligase complex. Capture of HIF-1 alpha by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1 alpha. The crystal structure of a hydroxylated HIF-1 alpha peptide bound to VCB (pVHL, elongins C and B) and solution binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL. Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues. This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under normoxia, PHDs hydroxylate conserved proline residues within HIF-α subunits, increasing their affinity for the von Hippel–Lindau (pVHL) E3 ubiquitin ligase complex, which promotes polyubiquitination and 26S proteasomal degradation”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [44]
In the citing paper
“The subsequent discovery of a peptide from hypoxia-inducible factor 1 subunit-α (HIF1α) that bound the E3 ligase von Hippel–Lindau tumour suppressor (VHL)18,19 led to the design of cell-penetrating PROTACs that degraded a range of POIs.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [18]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648 · cited 1×
“Cycles of rebuilding and refinement were carried out using the programs”
MethodHershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationAQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Research works printed but not linked: 1
- Hubbard, S. J. & Thornton, J. M. ‘NACCESS’, Computer Program Version 2.1.1 (Department of Biochemistry and Molecular Biology, Univ. Coll. London, London, 1996)
Cited by
Items 501–600 of 770
Wang, T., Meng, J., Li, L., & Zhang, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166057 · Cited by 14
Qiu, J., Zhang, K., Ma, K., Zhou, J., Gong, Y., Cai, L., & Gong, K. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.532588 · Cited by 15
Pfander, C., Knauth, K., Dambacher, S., & Buchberger, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm932 · Cited by 14
The C-terminus of CIS defines its interaction pattern
Lavens, D., Ulrichts, P., Catteeuw, D., Gevaert, K., Vandekerckhove, J. S., Peelman, F., Eyckerman, S., & Tavernier, J. H. (2006) · Biochemical Journal · doi:10.1042/bj20060242 · Cited by 13
Roles of hypoxia-inducible factor-prolyl hydroxylases in aging and disease
Galkin, F., Pulous, F. E., Fu, Y., Zhang, M., Pun, F. W., Ren, F., & Zhavoronkov, A. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102551 · Cited by 16
Expression and purification of functional recombinant CUL2•RBX1 from E. coli
Diaz, S., Li, L., Wang, K., & Liu, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-90770-x · Cited by 14
Ma, X., Tan, Z., Zhang, Q., Ma, K., Xiao, J., Wang, X., Wang, Y., Zhong, M., Wang, Y., Li, J., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00790-x · Cited by 16
Hasanov, E., Pimentel, I., Cruellas, M., Lewis, M. A., Jonasch, E. W., & Balmañà, J. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_350232 · Cited by 12
Lifshits, L. A., Rabin, M., Tohar, R., Netti, F., Gabay, M., Sova, M., Bar, D. Z., Weinberg, E., Adler‐Abramovich, L., & Gal, M. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c09059 · Cited by 12
Chen, Y., Zhu, L., Xue, S., Shi, J., He, C., & Zhang, Q. (2021) · Oncology Letters · doi:10.3892/ol.2021.12640 · Cited by 14
Hypoxia-inducible factor signaling in vascular calcification in chronic kidney disease patients
Çöpür, S., Uçku, D., Cozzolino, M. G., & Kanbay, M. (2022) · Journal of Nephrology · doi:10.1007/s40620-022-01432-8 · Cited by 14
“This post-translational proline hydroxylation exposes HIF-1α to the E3-ubiquitin-ligase complex, namely the von Hippel-Lindau (VHL) protein, targeting HIF-1α to proteasomal degradation, while asparagine hydroxylation prevents binding of HIF-1α to the transcriptional co-activator proteins, the CREB-binding protein (CBP…”
BackgroundHypoxia-Inducible Factor-1α and -2α Additively Promote Endothelial Vasculogenic Properties
Ben‐Shoshan, J., Maysel-Auslender, S., Luboshits, G., Barshack, I., Polak‐Charcon, S., Tzahor, E., Keren, G., & George, J. (2008) · Journal of Vascular Research · doi:10.1159/000181546 · Cited by 16
Molecular Biology of Kidney Cancer
Kaelin, W. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_3 · Cited by 12
Plants Get Hyp to O-Glycosylation
Mohnen, D., & Tierney, M. L. (2011) · Science · doi:10.1126/science.1208641 · Cited by 12
Peng, Z., Liu, X., Jin, M., Zhan, Y., Zhang, X., Bao, Y., & Liu, M. (2023) · Fishes · doi:10.3390/fishes8070359 · Cited by 12
SUMOylation indirectly suppresses activity of the HIF-1α pathway in intestinal epithelial cells
Malkov, M. I., Flood, D., & Taylor, C. T. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105280 · Cited by 11
“In normoxia, most O 2 is used by the mitochondria in the generation of ATP with the remaining “ spare ” O 2 facilitating hydroxylation of HIF by prolyl hydroxylase domain enzymes and factor-inhibiting HIF, leading to ubiquitin binding by the von Hippel – Lindau E3 ubiquitin ligase complex (2).”
Sayaf, A. M., Kousar, K., Suleman, M., Albekairi, N. A., Alshammari, A., Mohammad, A., Khan, A., Agouni, A., & Yeoh, K. K. (2024) · BMC Chemistry · doi:10.1186/s13065-024-01347-4 · Cited by 12
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity
Ling, J., Chen, H., Huang, M., Wang, J., & Du, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.074 · Cited by 13
Capturing cooperative interactions with the PSI-MI format
Roey, K. V., Orchard, S. E., Kerrien, S., Dumousseau, M., Ricard‐Blum, S., Hermjakob, H., & Gibson, T. J. (2013) · Database · doi:10.1093/database/bat066 · Cited by 11
Depoix, C. L., Flabat, O., Debiève, F., & Hubinont, C. (2016) · Reproductive Biology · doi:10.1016/j.repbio.2016.05.001 · Cited by 11
Protein Post-translational Modifications: Role in Protein Structure, Function and Stability
Mittal, S., & Saluja, D. (2015) · Springer eBooks · doi:10.1007/978-81-322-2467-9_2 · Cited by 15
Qian, H., Zou, Y. F., Tang, Y., Gong, Y., Qian, Z., Wei, G., & Zhang, Q. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c8cp01964a · Cited by 12
Utilizing comparative models in biomedical research
Little, A. G., Pamenter, M. E., Sitaraman, D., Templeman, N. M., Willmore, W. G., Hedrick, M. S., & Moyes, C. D. (2021) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2021.110593 · Cited by 18
Proteolysis targeting peptide (PROTAP) strategy for protein ubiquitination and degradation
Zheng, J., Tan, C., Xue, P., Cao, J., Liu, F., Tan, Y. C., & Jiang, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.158 · Cited by 11
Molecular chaperones: Guardians of tumor suppressor stability and function
Heritz, J. A., Backe, S. J., & Mollapour, M. (2024) · Oncotarget · doi:10.18632/oncotarget.28653 · Cited by 11
G protein-coupled receptor–targeted proteolysis-targeting chimeras in cancer therapeutics
Saca, V. R., Huber, T., & Sakmar, T. P. (2024) · Molecular Pharmacology · doi:10.1016/j.molpha.2024.100013 · Cited by 11
Macrocyclic peptides as a new class of targeted protein degraders
Jing, X., Mackay, J. P., & Passioura, T. (2025) · RSC Chemical Biology · doi:10.1039/d4cb00199k · Cited by 11
The Role of 2-Oxoglutarate-Dependent Oxygenases in Hypoxia Sensing
Wilkins, S. E., Flashman, E., Scotti, J. S., Hopkinson, R. J., Chowdhury, R., & Schofield, C. J. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782621959-00169 · Cited by 12
Self-citationHypoxia-Inducible Pathway Polymorphisms and Their Role in the Complications of Prematurity
Strauss, E., Gotz‐Więckowska, A., Sobaniec, A., Chmielarz-Czarnocińska, A., Szpecht, D., & Januszkiewicz‐Lewandowska, D. (2023) · Genes · doi:10.3390/genes14050975 · Cited by 11
“Ala588Thr), located in exon 12, have been extensively studied [19,20].”
BackgroundCastellani, B., Eleuteri, M., Bona, S. D., Cruciani, G., Desantis, J., & Goracci, L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01144 · Cited by 11
Jochmanová, I., & Lazúrová, I. (2014) · Biomedical Papers · doi:10.5507/bp.2014.021 · Cited by 10
Exploiting Ubiquitin Ligases for Induced Target Degradation as an Antiviral Strategy
Verma, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_13 · Cited by 11
Modular Protein Interaction Domains in Cellular Communication
Pawson, T. J., & Nash, P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00057-7 · Cited by 11
Review: Negative regulation of leptin receptor signalling.
Lavens, D., Piessevaux, J., & Tavernier, J. H. (2006) · PubMed · Cited by 14
V on H ippel– L indau Syndrome
Schimke, R. N., & Collins, D. L. (2005) · Wiley eBooks · doi:10.1002/0471695998.mgs052 · Cited by 10
Hydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell Growth
Bonardi, A., Nocentini, A., Luca, V. D., Capasso, C., Elkaeed, E. B., Eldehna, W. M., & Supuran, C. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810006 · Cited by 12
Song, S., Jing, W., Peng, L., Liu, J., & Tai, W. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00862 · Cited by 9
Okumura, F., Akiko, J.-O., Nakatsukasa, K., & Kamura, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175593 · Cited by 9
Iikuni, S., Watanabe, H., Shimizu, Y., Nakamoto, Y., & Ono, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243327 · Cited by 9
Narayan, V., & Jonasch, E. W. (2022) · Cancers · doi:10.3390/cancers14215313 · Cited by 10
Hydroxyproline metabolism enhances IFN-γ-induced PD-L1 expression and inhibits autophagic flux
Spangenberg, S. H., Palermo, A., Gazaniga, N. R., Martínez‐Peña, F., Guijas, C., Chin, E. N., Rinschen, M. M., Sander, P. N., Webb, B., Pereira, L. E., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.06.016 · Cited by 13
Rix, A. S., Grove, T. J., & O’Brien, K. M. (2017) · Polar Biology · doi:10.1007/s00300-017-2164-6 · Cited by 9
“…transactivation domain (CTAD) that is important for interactions with other transcription factors, two proline residues that are hydroxylated under normoxic conditions, and two nuclear localization signals (NLS) (Semenza et al. 1997; Lando et al. 2002; Hon et al. 2002; Sollid et al. 2006).”
Liu, Y., Lei, Y., Guo, S., & Zuo, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118495 · Cited by 9
Bedessem, B., & Stéphanou, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110495 · Cited by 11
Oxygen sensing; a stunningly elegant molecular machinery highjacked in cancer
Claesson, L. (2020) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2020.1769231 · Cited by 12
Corner, T. P., Salah, E., Tumber, A., Kaur, S., Nakashima, Y., Allen, M. D., Schnaubelt, L. I., Fiorini, G., Brewitz, L., & Schofield, C. J. (2024) · ChemMedChem · doi:10.1002/cmdc.202400504 · Cited by 10
Self-citationMoon, Y., Cho, H., Kim, J., Song, S., Park, J. Y., Min, J. Y., Han, E. H., Kim, Y., Seong, J., Shim, M. K., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202414146 · Cited by 9
Metabolic Effects of Succinate Dehydrogenase Loss in Cancer
Chatoff, A. G., Kantner, D. S., Snyder, N. W., & Rink, L. A. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70066 · Cited by 14
“Under hypoxic conditions, the reduced oxygen concentration inhibits prolyl hydroxylase ‐ mediated hydroxylation of HIF α proline residues, which reduces HIF α binding affinity for VHL and, consequently, HIF α ubiquitination and degradation (Hon et al. 2002; Min et al. 2002).”
Minervini, G., Lopreiato, R., Bortolotto, R., Falconieri, A., Sartori, G., & Tosatto, S. C. E. (2017) · Scientific Reports · doi:10.1038/srep46562 · Cited by 10
HIF2 ODD-luciferase reporter: the most sensitive assay for HIF prolyl hydroxylase inhibitors
Smirnova, N. A., Osipyants, A. I., Khristichenko, A. Y., Hushpulian, D. M., Nikulin, S. V., Chubar, T. A., Zakhariants, A. A., Tishkov, V. I., Gazaryan, I. G., & Poloznikov, A. A. (2018) · Russian Chemical Bulletin · doi:10.1007/s11172-018-2051-5 · Cited by 11
Iikuni, S., Kitano, A., Watanabe, H., Shimizu, Y., & Ono, M. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127596 · Cited by 8
Molecular Imaging of Hypoxia-Inducible Factor 1α and von Hippel-Lindau Interaction in Mice
Choi, C. Y. H., Chan, D. A., Paulmurugan, R., Sutphin, P. D., Le, Q., Koong, A. C., Zundel, W., Gambhir, S. S., & Giaccia, A. J. (2008) · Molecular Imaging · doi:10.2310/7290.2008.00017 · Cited by 10
Wetzel, G., Relja, B., Klarner, A., Henrich, D. M., Dehne, N., Brühne, B., Lehnert, M., & Marzi, İ. (2014) · Mediators of Inflammation · doi:10.1155/2014/930419 · Cited by 10
Xue, X., Zhao, N.-Y., Yu, H., Sun, Y., Chen, K., Huang, Q.-B., Sun, H.-P., Wang, X., & Li, N. (2016) · PeerJ · doi:10.7717/peerj.2757 · Cited by 34
“Starting from the minimal hydroxyproline recognition unit (Haifeng et al., 2002; Hon et al., 2002), Buckley and his coworkers reported a novel series of pyrrole derivatives to inhibit the HIF-1α/pVHL interaction with binding affinities at nanomolar range (Buckley et al., 2012b; Buckley et al.,…”
BackgroundImaging of Hypoxia in Retinal Vascular Disease
Feenstra, D. J., Drawnel, F., & Jayagopal, A. (2018) · InTech eBooks · doi:10.5772/intechopen.72252 · Cited by 8
Biología molecular del carcinoma de células claras renales: Principios para un tratamiento selectivo
Pulido, E. G., Centeno, A. M., Maroto, P., & Narbón, E. S. (2007) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(07)73628-8 · Cited by 8
Alcaide-German, M. L., Vara-Vega, A., García‐Fernández, L., Landázuri, M. O., & del Peso, L. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-18 · Cited by 8
“This fragment is sufficient for EGLN recognition [23] and VHL binding [ 36 ].”
Pugh, C. W. (2003) · Annals of Medicine · doi:10.1080/07853890310017062 · Cited by 11
Self-citationDixon, T., MacPherson, D., Mostofian, B., Dauzhenka, T., Lotz, S., McGee, D., Shechter, S., Shrestha, U. R., Wiewiora, R., McDargh, Z. A., et al. (2021) · doi:10.1101/2021.09.26.461830 · Cited by 7
Kurlekar, S., Lima, J. D. C. C., Li, R., Lombardi, O., Masson, N., Barros, A. B., Pontecorvi, V., Mole, D. R., Pugh, C. W., Adam, J., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3248 · Cited by 8
Self-citationJia, S., Qi, H., Shang, Z., Hua, X., Liang, A., Tian, Y., Wu, D., Jiang, Y., Liu, X., & Mao, C. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108626 · Cited by 7
The E3 ubiquitin-protein ligase MDM2 is a novel interactor of the von Hippel–Lindau tumor suppressor
Falconieri, A., Minervini, G., Bortolotto, R., Piovesan, D., Lopreiato, R., Sartori, G., Pennuto, M., & Tosatto, S. C. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-72683-3 · Cited by 7
Screening prolyl hydroxylase domain 2 inhibitory activity of traditional Chinese medicine by CZE‐UV
Zhang, Y., Zhao, M., Wang, C., Wang, Y., Nsanzamahoro, S., Zhu, L., Wang, W., & Yang, J. (2022) · Electrophoresis · doi:10.1002/elps.202200028 · Cited by 8
Mechanism study of ubiquitination in T cell development and autoimmune disease
Yu, H., Yang, W., Cao, M., Lei, Q., Yuan, R., He, X., Cui, Y., Chen, X., Su, X., Zhuo, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1359933 · Cited by 10
Sufian, M. A., Zamanova, S., Shabana, A. M., Kemp, B., Mondal, U. K., Supuran, C. T., & Ilies, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054595 · Cited by 9
Five decades of metalloenzymology
Hausinger, R. P. (2023) · The Enzymes · doi:10.1016/bs.enz.2023.03.001 · Cited by 7
The ubiquitin‐proteasome system—micro target for macro intervention?
Herrmann, J., Ciechanover, A. J., Lerman, L. O., & Lerman, A. (2005) · International Journal of Cardiovascular Interventions · doi:10.1080/14628840510011234 · Cited by 7
Santoni, G., Morelli, M. B., Santoni, M., & Nabissi, M. (2011) · Journal of Experimental and Integrative Medicine · doi:10.5455/jeim.290711.ir.006 · Cited by 7
“This hydroxylation allows for binding of the von-HippelLindau protein (pVHL), which mediates ubiquitination of HIF-1α and subsequent proteasomal degradation [34, 112-114].”
BackgroundInsights into the molecular features of the von Hippel–Lindau-like protein
Minervini, G., Quaglia, F., Tabaro, F., & Tosatto, S. C. E. (2019) · Amino Acids · doi:10.1007/s00726-019-02781-8 · Cited by 7
“Hydroxylated HIF-1α is then targeted for proteasomal degradation by pVHL, an E3 ubiquitin ligase complex substrate recognition element (Hon et al. 2002).”
BackgroundPrecise Identification of Native Peptides with Posttranslational Proline Hydroxylation by Nanopore
Chang, J.-W., Gao, Y., Zou, A., Li, M., Long, Y., & Jiang, J. (2025) · Angewandte Chemie · doi:10.1002/ange.202422692 · Cited by 9
Zhao, Y., Chen, F., Chen, C., Yang, Y., Wang, L., Zhu, J., Wang, X., Liu, Y., & Ding, J. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03408-9 · Cited by 7
Masarkar, N., Pal, M., Bisai, A., Yadav, A. K., Roy, M., Ray, S. K., Kanwar, J. R., & Mukherjee, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-20757-5 · Cited by 8
Enzyme-Linked Immunosorbent Assay for Pharmacological Studies Targeting Hypoxia-Inducible Factor 1α
Formento, J., Berra, E., Ferruà, B., Magné, N., Simos, G., Brahimi‐Horn, C., Pouysségur, J., & Milano, G. A. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.5.660-664.2005 · Cited by 9
Meenakumari, K. (2019) · Bioinformation · doi:10.6026/97320630015744 · Cited by 7
Orsi, J. B., de Araujo, L. S., Scariot, P. P. M., Polisel, E. E. C., Cardoso, L. O., Gobatto, C. A., & Manchado-Gobatto, F. D. B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115753 · Cited by 7
“Protein changes at the cellular level certainly contribute to physiological and physical performance adaptations [35–38].”
BackgroundLei, K., Li, J., Tu, Z., Gong, C., Liu, J., Luo, M. H., Ai, W., Wu, L., Li, Y., Zhou, Z., et al. (2024) · Theranostics · doi:10.7150/thno.98574 · Cited by 7
Time-resolved NMR detection of prolyl-hydroxylation in intrinsically disordered region of HIF-1α
He, W., Gasmi-Seabrook, G. M. C., Ikura, M., Lee, J. E., & Ohh, M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408104121 · Cited by 8
Fiorini, G., Marshall, S., Figg, W. D., Myers, W. K., Brewitz, L., & Schofield, C. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-75761-y · Cited by 8
“S7d), contrasting with observations in the previously reported structures of hydroxylated HIFα-CODD in complex with the von Hippel-Lindau protein and elongin B/C, where HyPro531 2α − CODD adopts the thermodynamically more favoured C4-exo conformation 59–61 .”
BackgroundResultSelf-citationEffect of N-acyl-dopamines on beta cell differentiation and wound healing in diabetic mice
Jiménez‐Jiménez, C., Lara‐Chica, M., Palomares, B., Collado, J. A., López‐Miranda, J., Muñóz, E., & Calzado, M. A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.08.008 · Cited by 6
Screening of prolyl hydroxylase 2 inhibitors based on quantitative strategy of peptides
Zhang, Y., Nsanzamahoro, S., Wang, C., Wang, W., & Yang, J. (2022) · Journal of Chromatography A · doi:10.1016/j.chroma.2022.463411 · Cited by 6
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
Stampone, E., Bencivenga, D., Capellupo, M. C., Roberti, D., Tartaglione, I., Perrotta, S., Ragione, F. D., & Borriello, A. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04852-2 · Cited by 9
Limaverde‐Sousa, G., Barreto, E. A., Ferreira, C. G., & da Rocha, J. C. C. (2012) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24191 · Cited by 8
Effect of proline analogues on the conformation of elastin peptides
Pepe, A., Crudele, M. A., & Bochicchio, B. (2013) · New Journal of Chemistry · doi:10.1039/c3nj41001c · Cited by 6
HIF-1α ODD polypeptides increased the expression of HIF1 and VEGF in hypoxic rat cortical neuron
Liu, X., Du, J., & Xi, Q. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0574-8 · Cited by 7
“In normoxia, hydroxylation of two proline residues at the oxygen-dependent degradation domain (ODDD) of HIF-1a trigger its association with pVHL E3 ligase complex, leading to HIF-1a degradation via ubiquitin–proteasome pathway [1–3].”
BackgroundGenetic insights into the hypoxia-inducible factor (HIF) pathway
Kiriakidis, S., Esteban, M. A., & Maxwell, P. H. (2007) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.12.009 · Cited by 6
Self-citationAlgorithmic assessment of missense mutation severity in the Von-Hippel Lindau protein
Fields, F. R., Suresh, N., Hiller, M., Freed, S. D., Haldar, K., & Lee, S. W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234100 · Cited by 7
Inducible Protein Degradation to Understand Genome Architecture
Tallan, A. M., & Stanton, B. Z. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00306 · Cited by 6
Evaluation of a Pooling Chemoproteomics Strategy with an FDA-Approved Drug Library
Sun, H., Yang, K., Zhang, X., Fu, Y., Yarbro, J. M., Wu, Z., Chen, P., Chen, T., & Peng, J. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00256 · Cited by 8
Velasquez, S. M., Iusem, N. D., & Estevez, J. M. (2011) · Plant Signaling & Behavior · doi:10.4161/psb.6.10.17135 · Cited by 6
VHL: Cullin-g the Hypoxic Response
Kershaw, N. J., & Babon, J. J. (2015) · Structure · doi:10.1016/j.str.2015.02.003 · Cited by 7
“Structural biology, in particular the structures of HIFa, VHL, and now VHL ier Ltd All rights reserved in complex with Cullin 2, have played an important role in both understanding VHL disease and the process of ubiquitination in general.”
BackgroundInfluentialKim, L., Lin, C.-C., Lin, T.-J., Cao, Y.-C., Chen, M., Chou, M.-Y., Lin, W.-H. W., Kim, M., Wu, J., Shih, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.19.504472 · Cited by 7
Xu, M., Ruan, Y., Gong, J., Xu, M., Shen, J., Wang, L., & Sun, X. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202521641 · Cited by 9
Guo, S., Liu, J., Zheng, H., & Wu, X. (2026) · Biomedicines · doi:10.3390/biomedicines14040835 · Cited by 7
The clinical landscape of HIF2α inhibitors in oncology
Saad, E., Machaalani, M., McDermott, D. F., & Choueiri, T. K. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01145-y · Cited by 6
“This hydroxylation event creates a recognition motif for the protein product of the VHL gene, pVHL (also known as VHL disease tumour suppressor), which functions as the substrate-receptor component of an E3 ubiquitin ligase complex 11,12 .”
Domene, C., Jorgensen, C., Vanommeslaeghe, K., Schofield, C. J., & MacKerell, A. D. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00411 · Cited by 6
“Journal of Molecular Biology 1996, 259 (4), 855-872; (b) Wojcik, J.”
Self-citationPalacios, D. S. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01491 · Cited by 6
Genotype-phenotype correlation of ocular von Hippel-Lindau disease in Koreans
Hwang, S., Kang, S. W., Kim, J.-W., & Kim, S. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311665 · Cited by 6
“Proper attachment of VHL to HIF-1 α is the first step of VHL-mediated degradation of HIF-1 α , with the attachment site being located within residues 65–117 [25, 26].”
BackgroundDevelopment of novel paullone-based PROTACs as anticancer agents
Manda, S., Chatakonda, V. K., Ugale, V. G., Tanwar, S., Raperthi, C., Borkar, M. R., Nale, P. E., Pasikanti, S., & Reddy, P. N. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.141273 · Cited by 6
Lolkema, M. P., & Voest, E. E. (2008) · Springer eBooks · doi:10.1007/978-1-84628-763-3_14 · Cited by 5
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma
D'Elia, A. V., Grimaldi, F., Pizzolitto, S., Maglio, G. D., Bregant, E., Passon, N., Franzoni, A., Verrienti, A., Tamburrano, G., Durante, C., et al. (2012) · Clinical Endocrinology · doi:10.1111/cen.12032 · Cited by 6
Metadata
- Authors
- Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Jones, E. Yvonne
- ORCID
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6892
- Pages
- 975-978
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2167786713
- Cited by
- 751
- References
- 31
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 37 · 2021: 35 · 2020: 43 · 2019: 19 · 2018: 24 · 2017: 23 · 2016: 28 · 2015: 24 · 2014: 20 · 2013: 23 · 2012: 26
- FWCI
- 17.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIF-1α, von Hippel-Lindau protein, E3 ubiquitin ligase, hypoxia, oxygen sensing, protein-protein binding, crystal structure, hydrogen bonding, ubiquitination, proteasomal degradation, transcriptional regulation
- MeSH terms
- Elongin, Amino Acid Sequence, Hypoxia, Binding Sites, Humans, Hydrogen Bonding, Hydroxylation, Hydroxyproline, Kinetics, Ligases, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Structure-Activity Relationship, Substrate Specificity, Transcription Factors, Sequence Alignment, Crystallography, X-Ray, Surface Plasmon Resonance, Amino Acid Motifs, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.